- NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
- NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
- NexImmune Announces 1-for-25 Reverse Stock Split
- NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy
- NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
More ▼
Key statistics
On Friday, Neximmune Inc (NEXI:NAQ) closed at 3.06, 144.78% above the 52 week low of 1.25 set on Nov 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.03 |
---|---|
High | 3.13 |
Low | 3.03 |
Bid | 3.01 |
Offer | 3.99 |
Previous close | 3.01 |
Average volume | 7.42k |
---|---|
Shares outstanding | 1.37m |
Free float | 1.07m |
P/E (TTM) | -- |
Market cap | 4.20m USD |
EPS (TTM) | -24.16 USD |
Data delayed at least 15 minutes, as of May 31 2024 17:52 BST.
More ▼